Dr. Charles Fisher, CEO of Unlearn AI, discusses creating digital clones by using artificial intelligence for use in clinical drug trials. He explains how a medical patient's data can be used to make a "digital twin" which can help speed up the testing of drugs.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Bloomberg Businessweek Weekend: July 31st 2026
38:26

Warsh Considers Fewer Fed Meetings; Anthropic AI Models Hack Three Organizations
40:03

Aon Keeps Margin Edge as Industry Tailwinds Fade
11:01